Heron Therapeutics is a biotechnology company that develops medicines to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer drug delivery technology, which can deliver therapeutic levels of a wide range of otherwise short-acting pharmacological agents over a period of days to weeks with a single injection. Its product portfolio includes SUSTOL, CINVANTI (HTX-019) and HTX-011. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.